These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15909594)

  • 1. 7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism.
    Chang JM; Lin SP; Kuo HT; Tsai JC; Tomino Y; Lai YH; Chen HC
    Clin Nephrol; 2005 May; 63(5):351-5. PubMed ID: 15909594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
    Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
    Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
    Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
    J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of chronic inflammation on bone turnover in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Antoniadi G; Kazila P; Dimitriadou M; Sotiriadou E; Koltsida M; Golfinopoulos S; Liakopoulos V; Christopoulou-Apostolaki M
    Ren Fail; 2008; 30(4):431-7. PubMed ID: 18569918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PTH and bone metabolism in chronic dialysis patients].
    Fukagawa M; Kazama J; Shigematsu T
    Rinsho Byori; 2001 Mar; 49(3):236-8. PubMed ID: 11307321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
    De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
    Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
    Coen G; Bonucci E; Ballanti P; Balducci A; Calabria S; Nicolai GA; Fischer MS; Lifrieri F; Manni M; Morosetti M; Moscaritolo E; Sardella D
    Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients.
    Sheth RD; Goldstein SL
    Pediatr Nephrol; 2005 Jul; 20(7):977-81. PubMed ID: 15856315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
    Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
    Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
    Ureña P; Prieur P; Pétrover M
    Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.
    Fehmi H; Osman Y; Bhat S; Nguyen K; Daramola O; Cantor T; Monier-Faugere MC; Yee J; Malluche HH
    Clin Nephrol; 2009 Mar; 71(3):267-75. PubMed ID: 19281737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
    Bednarek-Skublewska A; Chrapko B; Ksiazek A
    Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
    Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between whole and intact parathyroid hormone assays.
    Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.